Skip to main content
. 2020 Dec 9;20:589. doi: 10.1186/s12935-020-01649-2

Fig. 5.

Fig. 5

FBXL19 acted as an oncogene in glioma. a FBXL19 expression was examined by RT-qPCR in cells transfected with sh-FBXL19#1/2. b, c The proliferation was evaluated via colony formation and EdU assays (scale bar = 100 μm) in cells with the transfection of sh-FBXL19#1/2. d, e Cell apoptosis was assessed in different groups by caspase 3/8/9 activity detection and TUNEL assay (scale bar = 100 μm). f, g The stemness was appraised by sphere formation assay and RT-qPCR analysis of stemness-associated marker expressions in cells with orwithout -FBXL19 inhibition. **P < 0.01